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Dysmorphic features.
Midfrontal capillary haemangioma
Hook nose
Large posteriorly rotated dysplastic ears
Thin lips
Gum hypertrophy
Unusually large teeth (fusion inferior central-lateral incisor)
Large mouth
Retrognathia
Short neck
Sparse hair
Proximal implantation of the thumbsI won't be there anymore when these words are written. I died a
few years ago at the age of 18 years.
During pregnancy there was not one sign that something would go
wrong. I was the ﬁrst child of loving parents and was born 8 days after
the expected date. Although my birth was uncomplicated I was given
caffeine to stimulate my breathing but I was neither in need of
intubation or ventilation.
I had a normal birth weight (3.25 kg) and length (50 cm) and a
normal head circumference (35 cm).
The day after birth I was transferred to the Leuven University
Hospital because of a cardiac murmur and because I looked somewhat
bizarre (doctors call it ‘dysmorphic features’).
The heartmurmurwas due to a ventricular septal defect that didn't
trouble me in the following years. From then on doctors departed in
search of a syndrome. My parents didn't ﬁnd me that different or
abnormal. The dysmorphic features are listed in Table 1.
Leuven would become a second home to me and by a caprice of
fortune the ﬁrst senior doctor who examined me was the person who
would gave a name to my condition … more than 9 years later.
I have a long story to tell. My life course is summarized in Table 2
and a list of my problem domains is found in Table 3.
Some comments
Syndromes
First the doctors thoughtme to have Holt–Oram syndrome because
of the heart murmur, the dysmorphic symptoms and the fact that my
father was a little bit disproportionally built. But the ﬁt was far from
perfect. Then Langer–Giedion syndrome was put forward (trichorhi-
nophalangeal syndrome) — again based on some similarities. My
small testicles and the severe developmental delay raised the
hypothesis of Smith–Lemli–Opitz syndrome …
The big lower incisors (fused medial and lateral) were a striking
feature. A photograph was sent to professor Gorlin at Minnesota, an
expert in theﬁeld,who suggested otodental syndrome in the case I had
hearing problems (which I didn't have); otherwise he had no idea…
Finally professor Jaeken identiﬁed me as a – still rare – variant of
the syndrome that bears his name on the basis of an abnormal⁎ Corresponding author.
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doi:10.1016/j.bbadis.2009.02.001isoelectrofocusing proﬁle of serum sialotransferrins and he unraveled
the deviant metabolic pathway resulting in my clinical condition,
which is due to an autosomal recessive defect in the MGAT2 gene,
residing on chromosome 14q21 [1].
Development
I was a hypoactive and hypotonic baby. Clearly there was a delay in
visual maturation. The ﬁrst things that I seemed to have tracked
visually were the wedding photographs of my parents. Poor visual
interest was a problem for years.
Early motor and cognitive development were very slow: at the age
of 8 months – when most infants sit alone – I was comparable to a
baby of less than 2 months. At the age of 16 months – when most
toddlers walk – my developmental level was judged between 2 and
3 months. At 2 years I performed as a baby of 4–5 months and at the
age of 3 1/2 years I was able to sit without support. Nevertheless I
learned to walk and my parents were very proud that I could nearly
walk alone at 7 1/2 years, the age that I received my ﬁrst holy
communion. I never spoke a word, I never played in the real sense of
the word, but I made clear what was pleasant or unpleasant to me.
When I was ﬁve I went to a day centre in an institute for children
with a mental handicap. For my parents it was a confronting time and
they thought I was unhappy in that surrounding; moreover I was
suffering from recurrent respiratory infections. So when we moved to
a new house they kept me home. I had problems adapting to the newTapering ﬁngers
Hypotrophic distal limbs
Irregular position of the toes
Funnel chest
Kyphoscoliosis
Table 2
Life course.
0 year Birth
VSD
Dysmorphic features
1 year Big teeth (fusion lower incisors)
Gingival hypertrophy Severe developmental delay
1 year 5 m Gastrointestinal problems
2 Kyphosis
5 Epilepsy − start antiepileptic drugs Stunting growth
Brace for kyphosis
7 years 5 m Walks without support
7 years 9 m Birth of my brother
8 years 9 m Bleeding leads to detection
coagulopathy
9 years 5 m Deﬁnite diagnosis CDG syndrome
type II
10 years 6 m Worsening scolosis
12 years Worsening of epilepsy
1st respiratory distress episode
12 years 6 m Second bleeding after dental care
12 years 8 m Muscle wasting
17 years 3 m Melaena
18 years 7 m Exacerbation of epilepsy in
terminal phase
Respiratory insufﬁcient and
carbonarcosis leading to death
Table 3
Problem areas.
Eyes/vision Delayed visual maturation
ERG: lowered amplitude — VEP normal (3 y 9 m)
Slight myopia (−2D) at 9 y 2 m
Ears/hearing No hearing deﬁcit (BAEP normal at 9 y 4 m)
Malformed auricles
Orodental Fused lower incisors
Gum hypertrophy
High palate
Malposition/crowding of teeth
Maxillofacial Big open mouth
Retrognathia
Orthopedic Kyphosis
Progressive S-scoliosis
Hemivertebra C6
Fusion anomaly posterior arc L5
Osteoporosis
Elbow malformation (posteriorly luxated radius)
Valgus deviation feet
Gastrointestinal Problems deglutition
GE reﬂux — regurgitation
Volvulus of the stomach
GI bleeding — melaena
Obstipation
Anal ﬁssure
Cardiovascular Ventricular septal defect
Respiratory Recurrent respiratory infection
Died in carbonarcosis after respiratory insufﬁciency
Neurologic Severe mental handicap
Refractory epilepsy
Neuroimaging: normal MRI scan (9 y 4 m)
Genitourinary Urinary infections
Hydrocele (right side)
Small testes
Endocrine Stunted growth
Muscle wasting
Absence of puberty
Haemostasis Coagulopathy
Easy bruising
Gum bleeding, bleeding after dental care
GI bleeding, melaena
Immunologic Recurrent airway infections
Low serum IgG
Problematic lymphocyte growth (karyotyping failed 7 times!)
Drug reactions Side effects antipyretics (hypothermia)
Side effects antiepileptic drugs
(Carbamazepine: rash — topiramate: dysphagia)
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to a special school later on but that wasn't a success either, because I
was too disabled. At the age of twelve I was cared for in a special day
centre for the multiple handicapped.
I never used my hands to play although there was no major
problem of force or selectivity. My hand apraxia bears similarities with
what is seen in girls with Rett syndrome.
I enjoyed the presence of my younger brother be it that I must have
been a disappointing playmate for him.
Behaviour
Most of the time I was a pleasant and happy child. But I could be
very upset and bite my hands during episodes of excitation. The cause
of my irritability was often unclear which troubled my parents.
Sometimes the discomfort proved to be related to the medication (e.g.
the ‘throat’ problem as side-effect of topiramate), sometimes my
‘unhappiness’ was interpreted as resulting from gastrointestinal
dysfunction (reﬂux oesophagitis, constipation …) but most of the
time there was no explanation.
Also puzzling were my stereotyped behaviours: head movements,
hand–mouth behaviour.Fig. 1. Rx full spine (face and proﬁle) at the age of 18 y 5 m.
Fig. 2. Growth curves (height and weight).
846 P. de Cock, J. Jaeken / Biochimica et Biophysica Acta 1792 (2009) 844–846Orthopedic problems (see also Ref. [2])
While I remained very ﬂoppy I was given a sit orthosis (at ±18
months); at the age of 2 y 4m a kyphosis was noted and at 6 1/2 years I
got a brace which gave me more support and facilitated ambulation.
Between 7 and 8 years my spine started to deteriorate (although I was
rathermobile at that time); the kyphosis angle L1–L4measured 57° and
I developed an S-shaped scoliosis between 10 and 11 years. Despite the
brace and despite the absence of a growth spurt the Cobb angle
increased gradually from 40° to 58° in a few years time (Fig. 1).
The congenital anomalies (hemivertebra C6 — fusion anomaly of
the posterior arc of L5) were more epiphenomena than causal factors.
A spinal fusion was considered but the risks were estimated too
high (e.g. the risk of a severe bleeding).
Surprisingly my hips developed normally and never caused any
trouble.
Epilogue
During my last days and hours my parents were reassured that I
didn't suffer while fading out.
I died at the doorstep of adulthood in the presence of my family
and the doctors who took care of me for years.
I loved my parents and I say sorry for all the uncertainty, worries
and sorrow I provoked; unfortunately I wasn't able to tell them how
grateful I am for all the loving care I received.
Lessons
My personal case history intrigued many doctors for several
reasons:
1. Most physicians at that time assumed that the presence of
dysmorphic features equaled a constitutional etiology, i.c. a
cytogenetic abnormality, and that a metabolic disease had to be
suspected in an otherwise normal looking child with an acute
disturbance or severe mental delay. A possible exception was
Zellweger syndrome.
2. Interesting too is how the underlying metabolic cause was
discovered. A bleeding related to dental care led to a full
coagulation analysis which revealed abnormalities that at a closer
look resembled the pattern of deviant coagulation factors found in
CDG syndrome. It soon became apparent that there were
similarities with patients with a CDG variant previously described
by Vincent Ramaekers et al. (professor Jaeken being one of the co-
authors) [3]. The intuition that the bleeding episode wasn't an
ordinary one and the recognition of a speciﬁc coagulation pattern
were more than just a lucky coincidence: fortune favors the
prepared mind (Louis Pasteur).
3. The course of my condition resulting in juvenile death raises the
question if I suffered from a neurodegenerative disease. Themuscle
wasting, progressive scoliosis and death in respiratory insufﬁciencyresemble the course of a progressive neuromuscular disease. In this
respect the similarities with a mouse model are striking [4].
EMG and nerve conduction velocities were normal; neuroimaging
too (NMR) didn't reveal any abnormalities (e.g. no cerebellar
hypoplasia).
Questions
Many unanswered questions remain:
- the nature of the lifelong gastrointestinal dysfunctions even in
periods that my health condition was relatively stable
- the relation between CDG type II and (refractory) epilepsy
- the question if the growth stunting and absence of pubertal
development is primary or secondary (Fig. 2)
- the pathogenesis of the impressive orodental deformations with
the early appearance of gingival hypertrophy.
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